Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Melanoma Cells
100%
Multiple Cancers
100%
Cancer Pathways
100%
BRAF mutation
100%
BRAF-mutant Melanoma
60%
Oncogenic Pathways
30%
AZD6244
30%
Melanoma
20%
BRAF V600E
20%
A375
20%
Activation Patterns
10%
Drug Resistance
10%
Pathway Activity
10%
Targeted Therapy
10%
Hypoxia
10%
Pathway Activation
10%
IFN Pathway
10%
In Silico Methods
10%
In Silico
10%
Support Vector Machine Algorithm
10%
MEK Inhibitor (MEKi)
10%
Microarray Gene Expression
10%
Melanoma Treatment
10%
Support Vector Classifier
10%
Medicine and Dentistry
Melanoma Cell
100%
MEK Inhibitor
100%
Proteus Syndrome
100%
Melanoma
71%
Carcinogenesis
42%
Melanoma Cell Line
42%
Selumetinib
42%
Tumor Necrosis Factor
28%
In Silico
28%
Epidermal Growth Factor Receptor
28%
Targeted Therapy
14%
Malignant Neoplasm
14%
Drug Resistance
14%
DNA Microarray
14%
Hypoxia
14%
Biochemistry, Genetics and Molecular Biology
MEK Inhibitor
100%
Carcinogenesis
50%
Tumor Necrosis Factor
33%
Support Vector Machine
33%
Epidermal Growth Factor Receptor
33%
Drug Resistance
16%
DNA Microarray
16%
STAT3
16%
Targeted Therapy
16%
Immunology and Microbiology
Melanoma Cell
100%
Melanoma Cell Line
42%
Tumor Necrosis Factor
28%
Support Vector Machine
28%
Drug Resistance
14%
DNA Microarray
14%
STAT3
14%